TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
PGEN

Precigen Inc

Healthcare · Biotechnology

7.80$ +0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Precigen Inc (PGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 55 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PGEN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
49 46 54 54 46 77 44 45 32 43 23 36 23 8.4 30 30 24 19 3.4 3.8 3.3 3.7 5.5 2.9 17 1.8 1.9 1.8 1.4 1.2 1.1 0.7 1.0 1.2 1.3 0.9 2.9 4.6 23 55 86
15 14 16 17 15 15 15 19 15 14 15 17 15 14 14 15 23 14 11 1.4 1.5 14 13 1.8 14 1.3 1.5 1.7 1.5 2.6 1.9 1.0 1.0 1.2 1.4 1.6 1.4 1.9 2.9 2.8 8.9
34 32 38 38 31 62 29 27 17 29 8.0 19 8.2 -5.5 16 16 0.2 5.5 -8.1 2.5 1.9 -10 -8.0 1.1 2.5 0.5 0.3 0.1 -0.2 -1.3 -0.8 -0.3 -0.1 0.0 -0.1 -0.7 1.6 2.7 20 52 77
29 29 34 34 36 39 37 42 45 281 33 35 31 2.8 11 9.5 10 3.6 10 13 12 12 12 12 13 11 12 12 12 13 14 16 11 12 10 11 12 6.7 5.3 7.3 31
34 35 35 39 39 33 40 34 39 25 34 21 25 21 23 19 22 28 28 20 19 17 20 13 10 12 12 9.3 9.2 10 10 10 9.8 11 12 16 24 18 21 22 85
63 64 69 73 76 71 77 76 84 305 67 56 56 54 33 27 23 2.0 24 29 23 12 14 25 10 22 24 21 21 22 24 61 21 29 23 31 36 24 26 30 116
-29 -33 -31 -35 -45 -26 -48 -50 -66 -337 -59 -37 -49 -59 -17 -12 -23 3.5 -32 -26 -22 -22 -22 -24 -7.6 -22 -23 -21 -21 -23 -24 -61 -21 -29 -23 -32 -34 -22 -6.0 23 -39
0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 4.0 4.3 4.3 4.4 4.5 4.5 4.6 4.6 4.6 4.6 4.5 4.6 4.8 4.9 2.0 2.1 2.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.0 2.9 3.0 9.7
-30 -45 -33 -20 -42 -35 -47 -68 -73 -344 -63 -39 -54 -52 -21 -16 -28 -0.9 -27 -31 -26 -27 -24 -26 -7.7 -22 -23 -20 -20 -33 -24 -60 -24 -20 -54 -27 -146 -24 -7.9 20 -158
-0.4 -0.6 -0.5 -0.8 -0.8 -0.7 -4.1 -1.1 -14 -2.0 -0.6 -0.5 -0.5 0.7 0.0 -0.1 -0.1 0.0 -0.1 -0.1 -0.1 0.0 -0.1 -0.1 -0.1 0.0 -0.1 -0.1 0.0 -0.3 0.0 -1.7 0.0 -0.1 -0.1 0.0 179 0.0 – – –
-29 -44 -31 -19 -40 -27 -42 -65 -57 -340 -61 -39 -54 -169 -57 -43 -30 -42 -17 -20 -30 -25 -19 -18 87 -22 -23 -20 -20 -33 -24 -59 -24 -20 -54 -27 -146 -24 -7.9 20 -158
-24 -38 -25 -13 -34 -26 -39 -59 -61 -331 -52 -29 -39 -42 -11 -6.5 -18 7.5 -19 -23 -18 -14 -20 -21 -3.8 -20 -21 -19 -18 -32 -22 -59 -23 -19 -54 -27 -145 -19 -3.9 23 -145

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?